Recall Enforment Report D-0482-2015

Recall Details

Multi event Drug Recall Enforcement Report Class II voluntary initiated by Hospira Inc., originally initiated on 01-23-2015 for the product KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3795-01 --- Also labeled under NOVAPLUS label NDC 0409-3795-49 The product was recalled due to crystallization. The product was distributed nationwide and the recall is currently terminated.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-0482-201501-23-201504-15-2015Class IIHOSPIRA = 13,720,475 vials, NOVAPLUS = 1,528,500 vialsKETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3795-01 --- Also labeled under NOVAPLUS label NDC 0409-3795-49CrystallizationTerminated
D-0483-201501-23-201504-15-2015Class IIHOSPIRA = 4,339,500 vials. NOVAPLUS = 341,100 vialsKETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49CrystallizationTerminated

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0409-3793Ketorolac Tromethamine Hospira, Inc.
0409-3793Ketorolac Tromethamine Ketorolac TromethamineInjection, SolutionIntramuscular; IntravenousHospira, Inc.Human Prescription Drug
0409-3795Ketorolac Tromethamine Hospira, Inc.
0409-3795Ketorolac Tromethamine Ketorolac TromethamineInjection, SolutionIntramuscular; IntravenousHospira, Inc.Human Prescription Drug
0409-3796Ketorolac Tromethamine Hospira, Inc.
0409-3796Ketorolac Tromethamine Ketorolac TromethamineInjection, SolutionIntramuscularHospira, Inc.Human Prescription Drug